HomeGANX • NASDAQ
add
Gain Therapeutics Inc
Previous close
$2.10
Day range
$1.97 - $2.08
Year range
$1.41 - $2.81
Market cap
72.52M USD
Avg Volume
819.10K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.37M | -37.28% |
Net income | -5.81M | 28.66% |
Net profit margin | — | — |
Earnings per share | -0.19 | 54.76% |
EBITDA | -5.09M | 37.80% |
Effective tax rate | -2.49% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.69M | -60.47% |
Total assets | 9.83M | -48.77% |
Total liabilities | 6.14M | -17.18% |
Total equity | 3.70M | — |
Shares outstanding | 35.95M | — |
Price to book | 17.50 | — |
Return on assets | -118.71% | — |
Return on capital | -236.67% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -5.81M | 28.66% |
Cash from operations | -5.10M | 11.42% |
Cash from investing | — | — |
Cash from financing | 2.47M | -75.42% |
Net change in cash | -2.37M | -137.68% |
Free cash flow | -3.00M | -20.23% |
About
Founded
2017
Website
Employees
24
